Thanks to the safety scrutiny on the JAK inhibitor class of drugs, AbbVie’s optimism for its Humira follow-on Rinvoq might have shifted from unbridled to cautious. But in the meantime, the versatile ...
With megablockbuster Humira in its sunset years as a $20 billion-per-year behemoth, AbbVie is positioning two next-gen launches to pick up the slack. The more recent, JAK med Rinvoq, is off to a ...
Humira (adalimumab) has potential interactions with several other drugs. For example, taking prednisone with Humira can increase the risk of side effects from both drugs. Humira may also interact with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback